Schonfeld Strategic Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-97,529
| Closed | -$2.37M | – | 1989 |
|
|
2025
Q1 | $2.37M | Buy |
97,529
+24,549
| +34% | +$595K | 0.01% | 778 |
|
|
2024
Q4 | $1.52M | Buy |
+72,980
| New | +$1.52M | 0.01% | 889 |
|
|
2024
Q1 | – | Sell |
-16,887
| Closed | -$284K | – | 1927 |
|
|
2023
Q4 | $284K | Buy |
+16,887
| New | +$284K | ﹤0.01% | 1359 |
|
|
2022
Q4 | – | Sell |
-176,506
| Closed | -$2.27M | – | 2566 |
|
|
2022
Q3 | $2.27M | Buy |
+176,506
| New | +$2.27M | 0.02% | 809 |
|
|
2022
Q2 | – | Sell |
-23,288
| Closed | -$193K | – | 2518 |
|
|
2022
Q1 | $193K | Buy |
+23,288
| New | +$193K | ﹤0.01% | 1930 |
|
|
2018
Q1 | – | Sell |
-38,997
| Closed | -$153K | – | 770 |
|
|
2017
Q4 | $153K | Buy |
+38,997
| New | +$153K | 0.01% | 682 |
|